Gene · 148
Papers1,657
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,657
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased length-dependent activation of human engineered heart tissue after chronic α1A-adrenergic agonist treatment: testing a novel heart failure therapy. | Am J Physiol Heart Circ Physiol | 2023 | 36637971 | PubTator, text mining | PubMed |
| Effect of α1D-adrenoceptor blocker for the reduction of ureteral contractions. | Investig Clin Urol | 2023 | 36629069 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| TXNIP DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study. | BMJ Open Diabetes Res Care | 2023 | 36604111 | PubTator, text mining | PubMed |
| Characterization of a novel positive allosteric modulator of the α1A-Adrenergic receptor. | Curr Res Pharmacol Drug Discov | 2023 | 36544813 | PubTator, text mining | PubMed |
| Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences. | J Mol Struct | 2023 | 36467615 | PubTator, text mining | PubMed |
| GC-MS and Network Pharmacology Analysis of the Ayurvedic Fermented Medicine, Chandanasava, Against Chronic Kidney and Cardiovascular Diseases. | Appl Biochem Biotechnol | 2023 | 36418713 | PubTator, text mining | PubMed |
| Inhibition of signaling downstream of beta-2 adrenoceptor by propranolol in prostate cancer cells. | Prostate | 2023 | 36373761 | PubTator, text mining | PubMed |
| Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis. | Digestion | 2023 | 36366816 | PubTator, text mining | PubMed |
| Small Molecule Tools to Study Cellular Target Engagement for the Intracellular Allosteric Binding Site of GPCRs. | Chemistry | 2023 | 36193681 | PubTator, text mining | PubMed |
| Calcium-channel blockers: Clinical outcome associations with reported pharmacogenetics variants in 32 000 patients. | Br J Clin Pharmacol | 2023 | 36134646 | PubTator, text mining | PubMed |
| Mammalian puberty: a fly perspective. | FEBS J | 2023 | 35607827 | PubTator, text mining | PubMed |
Effectiveness and safety of selected traditional Chinese medicine injections in patients with combined diabetes mellitus and coronary heart disease: A systematic review and network meta-analysis of randomized clinical trials. | Front Pharmacol | 2022 | 36699083 | PubTator, text mining | PubMed |
| Mechanism of Datura metel on sinus bradycardia based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36626429 | PubTator, text mining | PubMed |
| Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking. | Comput Math Methods Med | 2022 | 36590764 | PubTator, text mining | PubMed |
| Graph regularized non-negative matrix factorization with prior knowledge consistency constraint for drug-target interactions prediction. | BMC Bioinformatics | 2022 | 36581822 | PubTator, text mining | PubMed |
| Neuropharmacological Activities of Ceiba aesculifolia (Kunth) Britten & Baker f (Malvaceae). | Pharmaceuticals (Basel) | 2022 | 36559031 | PubTator, text mining | PubMed |
| Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge Xestospongia sp., in Mediating Non-Small-Cell Lung Cancer Cell Apoptosis. | Molecules | 2022 | 36558080 | PubTator, text mining | PubMed |
| The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases. | Int J Mol Sci | 2022 | 36555676 | PubTator, text mining | PubMed |
| Conventional Ameloblastoma. A Case Report with Microarray and Bioinformatic Analysis. | Diagnostics (Basel) | 2022 | 36553196 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/148/papers?page=7